Viewing Study NCT04208958


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-01-02 @ 6:08 PM
Study NCT ID: NCT04208958
Status: COMPLETED
Last Update Posted: 2025-10-27
First Post: 2019-12-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
Sponsor: Vedanta Biosciences, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: VE800-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View